Resolute Capital Asset Partners LLC

All holdings · as of Dec 31, 2025

Company	Class	Value	Shares	% of portfolio
ASP Isotopes Inc.	—	$267.5K	50,000	0.1%
PepGen Inc.	—	$325.5K	50,000	0.2%
SPRUCE BIOSCIENCES, INC.SPRB	Common Stock	$348.4K	4,000	0.2%
Oruka Therapeutics, Inc.	—	$378.9K	12,500	0.2%
Quoin Pharmaceuticals Ltd.	—	$432.9K	30,000	0.2%
TERAWULF INC.	—	$459.6K	40,000	0.2%
Aura Biosciences, Inc.AURA	Common Stock	$496.0K	91,006	0.2%
Xeris Biopharma Holdings, Inc.	—	$785.0K	100,000	0.4%
PALISADE BIO, INC.	—	$940.0K	400,000	0.5%
TIC Solutions, Inc.	—	$1.01M	100,000	0.5%
HALLADOR ENERGY CO	—	$1.33M	70,000	0.6%
Rocket Companies, Inc.	—	$1.45M	75,000	0.7%
CHEVRON CORP	—	$1.52M	10,000	0.7%
Replimune Group, Inc.	—	$1.70M	175,000	0.8%
HEXCEL CORP /DE	—	$1.85M	25,100	0.9%
Amentum Holdings, Inc.	—	$2.03M	70,000	1.0%
LINDE PLC	—	$2.13M	5,000	1.0%
HUBBELL INC	—	$2.22M	5,000	1.1%
UNIVERSAL TECHNICAL INSTITUTE INC	—	$2.35M	90,000	1.1%
TEXAS INSTRUMENTS INC	—	$2.60M	15,000	1.3%
Progyny, Inc.	—	$2.71M	105,699	1.3%
First American Financial Corp	—	$2.76M	45,000	1.3%
EQT Corp	—	$3.02M	56,402	1.5%
DARLING INGREDIENTS INC.	—	$3.06M	85,000	1.5%
CARPENTER TECHNOLOGY CORP	—	$3.15M	10,000	1.5%
Vistra Corp.	—	$3.23M	20,000	1.6%
KIRBY CORP	—	$3.31M	30,000	1.6%
AUTOZONE INC	—	$3.73M	1,100	1.8%
Amrize Ltd	—	$3.79M	70,000	1.8%
NRG Energy Inc	—	$3.98M	25,000	1.9%
Cytokinetics Inc	—	$4.13M	65,000	2.0%
AAR CORP	—	$4.14M	50,000	2.0%
APi Group Corp	—	$4.40M	115,000	2.1%
Bunge Global SA	—	$4.45M	50,000	2.2%
Glaukos Corp	—	$4.57M	40,500	2.2%
DANAHER CORP /DE	—	$4.58M	20,000	2.2%
SYNOPSYS INC	—	$4.70M	10,000	2.3%
SCHWAB CHARLES CORP	—	$5.50M	55,000	2.7%
Crane Co	—	$5.53M	30,000	2.7%
THERMO FISHER SCIENTIFIC INC.	—	$5.79M	10,000	2.8%
MADRIGAL PHARMACEUTICALS, INC.	—	$6.36M	10,918	3.1%
Jazz Pharmaceuticals PLC	—	$6.80M	40,000	3.3%
Cidara Therapeutics Inc	—	$8.24M	37,315	4.0%
Abivax Sa	—	$8.77M	65,000	4.2%
Alphabet Inc.	—	$9.41M	30,000	4.5%
Texas Pacific Land Corp	—	$13.07M	45,500	6.3%
Andersons, Inc.	—	$13.82M	260,000	6.7%
Amazon.com Inc	—	$16.42M	71,158	7.9%
ASCENDIS PHARMA A/S	—	$18.90M	88,627	9.1%